Science and technology for the health sector
and their application in prevention and care for people
HEALTH AND WELLNESS
GENETIC AND EPIGENETIC DIAGNOSIS
In ARQUIMEA we work in the development of genetic and epigenetic tests in different medical specialties, with which we complete the diagnosis, detecting certain alterations in health to try to prolong the time until their manifestation or even to avoid their appearance.
Well_iD THE WELLNESS ID TEST
GENETIC SKIN TEST
Well_iD Derma is a genetic test, for professional use only, that determines with a sensitivity of more than 99% the genetic predisposition to premature aging and other alterations that affect the health and well-being of the skin. The genetic test allows to complete the visual and tactile examination of the skin, through a personalized and objective diagnosis, as well as to enhance the effectiveness of treatments to achieve better results.
From the Consumer Health line, ARQUIMEA develops innovative products to help people take care of their health and well-being. Mainly focused on natural solutions for self-consumption that can be found in pharmacies.
SILUETE HEALTHY BALM
INNOVATIVE LIP BALM THAT HELPS TO AVOID SNACKING
Siluete helps to avoid snacking through a unique and refreshing sensory experience. Its ingredients of 100% natural origin, from plant extracts and essential oils, help to curb the sudden urge to snack and lead to a more balanced diet. Its patented formula has been developed by nutritionists using the best cutting-edge technology and its efficacy is supported by clinical studies.
COMPREHENSIVE COVID-19 SERVICE
ARQUIMEA has vast experience in developing and managing COVID-19 testing services and safety protocols. Our activity has not stopped since the start of the pandemic in March 2020.
Our tests are characterized by their high-quality reagents, ensuring their high specification, and by our certified laboratories’ processing capacity, allowing us to offer results in record time.
The solutions are focused in three main areas of action: public administration, in order to perform massive testing to the population; private sector, working with different sectors to provide not only the analysis service, but also the safety protocols; and final consumer with innovative solutions of extraction and analysis on laboratories, airports and home test.
COVID-19 TESTS IN MADRID AND BARCELONA
We offer a global service to diagnose COVID-19 through the partnership called Alianza COVID-19 with biotechnology companies and certified laboratories in Madrid and Barcelona.
We have sample collection clinics located in Madrid and Barcelona to access COVID-19 Testing: PCR, Rapid Antigen Test or Rapid Antibody Test. We also offer a COVID home testing service: saliva PCR and ELISA antibody test. The patient can choose to have the test done at home or in one of our laboratories in Madrid or Barcelona.
FLY COVID TEST CENTER
COVID-19 TESTS AT AIRPORTS
We have sample collection clinics located at Barcelona, Madrid, Malaga, Seville, Jerez, Bilbao and Canary Islands airports to increase travellers’ access to COVID-19 Testing, as they can take a PCR, Rapid PCR, Rapid Antigen Test or Rapid Antibody Test before catching their flight.
International travellers can have their sample collected and get their test results on the same day. When taking a Rapid Antigen Test or a Rapid Antibody Test, results will be available in 15-20 minutes, while PCR test results will be sent within 12 hours and Rapid PCR within 35 minutes.
INVESTMENT IN R&D
From the Healthcare area we participate and invest in different companies for the development of innovative therapies for various diseases, still unresolved, transferring scientific research to society.
Founded as a spin-off from CSIC and belonging to ARQUIMEA, is a company dedicated to research and development for the creation of molecules, compounds and drugs for medicinal and therapeutic purposes, in the NS.
Is a research center that develops epigenetic diagnostic tools, characterizes new epigenetic drugs and stimulates translational research with the aim of improving people’s health and well-being.
Atlas Molecular Pharma
Is focused in discovering first-in-class, innovative therapeutics for the treatment of Rare and Ultra-Rare Diseases in order to improve patients quality of life.
Founded as a spin-off from the Institute of Biomedicine of Seville and the University of Seville, works with an international network of collaborators on development of multi-valent vaccines for preventing antibiotics-resistant infections in all regions of the world.
Is a biotechnology platform focused on the research and development of innovative systems for the safe, reliable and rapid diagnosis of viral infections such as COVID-19, Hepatitis C, Zika or African swine fever, among others.
Ready to take the leap?
Let us help you.